A new study reveals details on how U.S. hospitals exploited a loophole in the Medicare outlier payments program, reaping billions of dollars in excess revenue.
Lab group sues FDA over final rule regulating laboratory-developed tests
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
May 31, 2024